Long-term treatment of acromegaly with octreotide (Sandostatin).

Page, M D; Millward, M E; Hourihan, M; Hall, R; Scanlon, N F

Page, M D; Millward, M E; Hourihan, M; Hall, R; Scanlon, N F.

Affiliation

Page MD; Department of Medicine, University of Wales College of Medicine, Cardiff, UK.

Horm Res ; 33 Suppl 1: 20-30; discussion 30-1, 1990.

Article in En | MEDLINE | ID: mdl-2192978

Subject(s)

Acromegaly/drug therapy; Octreotide/therapeutic use; Adult; Aged; Blood Glucose; Female; Growth Hormone/blood; Humans; Insulin/blood; Insulin-Like Growth Factor I/analysis; Male; Middle Aged; Octreotide/adverse effects; Pituitary Neoplasms/complications; Prolactin/blood; Thyroid Gland/drug effects; Thyrotropin/biosynthesis; Thyroxine/biosynthesis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Acromegaly / Octreotide Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Horm Res Year: 1990 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links